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Review Article 
A Novel Regulatory Mechanism of Apoptosis by Calreticulin, 
a Molecular Chaperone in the Endoplasmic Reticulum
Yoshito IHARA
Department of Biochemistry and Molecular Biology in Disease, Atomic Bomb Disease Institute, Nagasaki University Graduate School of 
Biomedical Sciences
 Calreticulin (CRT) is a Ca"--binding lectin-like molecular 
chaperone of the lumen of the endoplasmic reticulum. 
Recently, CRT has been revealed to be a multi-functional 
molecule related with glycoprotein maturation and chaper-
one function, Ca" homeostasis, cell adhesion, cell signaling, 
transcriptional regulation, and nuclear transporting mecha-
nisms. CRT is also essential for cardiac and neural develop-
ment in mice, suggesting an importance in the regulation 
of cell survival and death during development. 
 To examine the role of CRT in cardiac differentiation, we 
established CRT-overexpressiog myocardiac H9c2 cells, and 
investigated the effect of the overexpression on cardiac 
differentiation in vitro. We found that the cells transfected 
with the CRT gene were highly susceptible to apoptosis 
compared with controls. In the gene-transfected cells, Akt/ 
protein kinase B signaling was significantly suppressed 
during the differentiation. Furthermore, PP2A, a Ser/Thr 
protein phosphatase, was significantly upregulated imply-
ing a suppression of Akt signaling due to dephosphorylation 
of Alit by the upregulated PP2A via the regulation of Ca` 
homeostasis. Thus, overexpression of CRT promotes differ-
entiation-dependent apoptosis in H9c2 cells by suppressing 
the Akt signaling pathway. Our findings demonstrate a 
novel mechanism in which cytoplasmic Akt signaling is 
modulated to cause apoptosis by a resident protein of the 
endoplasmic reticulum, CRT. 
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Introduction 
 Apoptosis or programmed cell death is an important 
physiological process that plays a pivotal role in de-
velopment and tissue homeostasis. However, apoptosis 
is also involved in a variety of pathological processes 
and conditions." Numerous diseases involve too much 
apoptosis (e.g., neurodegenerative diseases, Parkinson's 
disease, Alzheimer's disease, spinal muscular atrophy, 
AIDS) or too little apoptosis (e.g., cancer or autoimmune 
diseases [type I diabetes, encephalomyelitis]). Some 
toxins and forms of cellular stress can also trigger 
apoptosis (e.g., oxidative stress, alcohol, radiation). 
 During the past decade research into the mechanism 
of apoptosis has made extensive progress. The re-
search has revealed that apoptosis is regulated by sev-
eral important molecular mechanisms involving 
caspases and their substrates, the Bcl-2 family and 
mitochondrial functions, death ligands and receptors 
such as the Fas receptor .2' Although DNA damage in 
the nucleus and the ligation of plasma-membrane 
death receptors have long been recognized as initial 
triggers of apoptosis, other organelles including the 
endoplasmic reticulum (ER), lysosome, and Golgi appa-
ratus are also major points of integration of pro-
apoptotic signaling.') 
 The ER senses local stress through chaperones, Ca2+-
binding proteins and Ca2+-releasing channels, which 
might transmit Ca 2' responses to mitochondria. The 
ER contains several Bcl-2-related proteins" ' 5 n, and Bcl-
2 has been reported to express an anti-apoptotic effect 
at the ER. 3' 
 In this review, I focus on calreticulin (CRT), a 
unique multi-functional protein in the ER, and de-
scribe and discuss our novel finding that CRT plays a
critical role in the regulation of apoptosis in 
myocardiac H9c2 cells.
CRT, a Ca` -binding protein 
 CRT is a Ca"-binding molecular chaperone in the 
ER." 7' CRT was first isolated as a Ca2+-binding pro-
tein by Ostward and MacLennan in 1974." Its cDNA 
was then cloned in 1989 by Smith and Koch g' and 
Fliegel et al.10' CRT is a 46 kDa protein with a 
cleavable N-terminal amino acid signal sequence and 
the C-terminal sequence Lys-Asp-Glu-Leu (KDEL), a re-
trieval signal in the ER. With these specific amino 
acid sequences, CRT is localized in the ER. It is a 
highly conserved protein with over 90% amino acid 
identity in mammals including human, rabbit, rat and 
mouse. 6' It is also known that calnexin (CNX), another 
membrane-binding homologue of CRT, shares the 
chaperone function in the ER.", 12' Based on structural 
and functional studies, CRT can be divided into three 
distinct domains; N-terminal [N], proline-rich [P], and 
C-terminal [C] (Fig. 1).') The globular N-domain of 
CRT has been modeled based on crystallographic data 
for CNX.13' The proline-rich P-domain shows a charac-
teristic structure with an extended and curved arm 
connected to a globular N-domain. The domain con-
tains three sets of two characteristic repeats 1 (-Ileu-X-
Asp-Pro-Asp / Glu-Ala-X-Lys-Pro-Glu-Asp-Trp-Asp-Asp / 
Giu-) and 2 (-Giy-X-Trp-X-X-Pro-X-lieu-Asn-X-Pro-X-Y-). 
The N-terminal region encompassing the N and P-
domain of CRT interacts with misfolded proteins and 
glycoproteins, binds ATP, Zn2+ and Ca 21 with high af-
finity and low capacity, and is likely to be involved in 
chaperone function of the protein." 16' The C-domain 
binds Ca2- with high capacity and plays a role in Ca" 
storage in the ER in vivo 6', though no structural infor-
 Arm domain 
   [ P-domain ] 
(ERp57 binding site + 
Chaperone function + 
Ca2+ binding) 
Globular domain 
   
[ N-domain ] 
(Lectin site + 
Chaperone function) 
   [ C-domain ] 
  (Ca2+ binding)
Figure 1. Schematic representation of the CRT structure.
mation is available at present. The CRT gene is 
upregulated by ER stress such as unfolded protein re-
sponses"' and deprivation of Ca" in the ER.")
The functions of CRT in the cell 
 CRT is involved in many biological processes in-
cluding the regulation of glycoprotein folding, Ca" ho-
meostasis and intracellular signaling, cell adhesion, 
gene expression, and nuclear transport.'- 7'
[1] CRT, a lectin-like molecular chaperone in the ER 
  Molecular chaperones are the proteins that suppress 
the aggregation of unfolded proteins and help with 
the proper folding of misfolded proteins during the 
synthesis of new proteins or conditions of cellular 
stress.", 19' The molecular chaperone function of CRT was 
first reported for myeloperoxidase20' and hemmagulutinin
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Figure 2. Molecular chaperones and folding of secretory 
glycoproteins in the ER. 
Newly synthesized polypeptides of secretory proteins were 
transported into the ER through the polypeptide transporter 
complex, translocon. The polypeptide was properly folded in 
the ER with the help of molecular chaperones, such as BiP, 
Grp94, protein disulfide isomerase (PDI), ERp57, CRT, CNX 
and so forth. In the case of N-glycoproteins, the oligosaccharide 
of Glc3Man9GlcNAc2 is attached by oligosaccharyltranferase 
(OST) to the Asn residue contained in the consensus se-
quence Asn-X-Ser/Thr, of newly synthesized polypeptides. 
The oligosaccharides were processed with glucosidase-I (G-I) 
and II (G-II), and then CNX or CRT bound the G1cIMan5-
9GIcNAc in the glycoproteins. If the glycoprotein is com-
pletely folded, the terminal glucose is removed by G-II and 
the glycoprotein is released from the CNX/CRT to exit 
the ER. However, if the glycoprotein is not properly folded, 
the terminal glucose is once again attached by the action 
of UDP-Glc: glycoprotein glucosyltransferase (UGGT). 
Nevertheless, if proper folding is not accomplished, the 
misfolded glycoprotein is transported to the cytosol for deg-
radation by proteasomes (ER-associated degradation: ERAD).
of influenza virus"', with various other substrates 
then identified for CRT-binding."' The molecular 
mechanism of the substrate-binding has been well 
characterized in the case of CNX, the membrane-
bound homologue of CRT"-"', and is similar to that of 
CRT29-32) (Fig. 2). In the biosynthesis of N-glycoproteins 
in the ER, the oligosaccharide Glc3Man9GlcNAc2 is 
attached to the Asn residue contained in the consen-
sus sequence Asn-X-Ser/Thr, of newly synthesized 
polypeptides.33' The oligosaccharides are processed by 
glucosidase-I and II, and then CNX or CRT binds the 
Glc l Mans-9GlcNac in glycoproteins.25. 29) The N-domain 
of CRT and CNX is speculated to be the oligosaccharide-
binding site (lectin site).") If the glycoprotein is com-
pletely folded in the ER, the terminal glucose is re-
moved by glucosidase-II and the glycoprotein is 
released from the CNX/CRT chaperone cycle (Fig. 2). 
However, if the glycoprotein is not properly folded, 
the terminal glucose is once again attached by the action 
of UDP-Glc: glycoprotein glucosyltransferase (UGGT), 
which discriminates between folded and unfolded sub-
strates.3A' Together, CRT and CNX form a specific 
chaperone cycle for the biosynthesis of glycoproteins 
in the ER (Fig. 2).33' Because of the binding-preference 
of CNX/CRT to oligosaccharides in the substrates, 
CNX and CRT are called "lectin-like chaperones". 
However, protein-protein interaction between CNX/CRT 
and substrates is suggested .11, 26, 32) Further investiga-
tion is required to clarify the overall CNX/CRT chap-
erone cycle. In addition to CRT and CNX, the ER con-
tains other molecular chaperones and related enzymes, 
such as BiP/Grp78, Grp94, ER protein 57 (ERp57), and 
protein disulfide isomerase (PDI), thought to form a 
chaperone network in the ER. CRT and CNX function 
with the help of other chaperones such as ERp5735' or 
BiP/GRp78.28' The binding site for ERp57 has been iden-
tified in the P-domain of CRT or CNX (Fig. 1).14, '5)
[2] CRT, a regulator of Ca" homeostasis in the ER 
 The ER is the main reservoir of intracellular Ca" 
and plays an important role in Ca" homeostasis."' The 
concentration of Ca" in the ER is maintained at ap-
proximately 400 FuM, which is in contrast with the 
level of cytoplasmic free Ca" (-100 nM).37 CRT has 
two Ca"-binding sites and this characteristic contrib-
utes to the function of the ER as a Ca" reservoir. It 
is known that a high affinity, low capacity (Kd = 1 p M) 
and a low affinity, high capacity (Kd = 2 mM) CaZ+-
binding sites are present in the P and C-domain, re-
spectively.') Ca 21 is released from the ER by receptors 
for inositol-1,4,5-trisphosphate and ryanodine, and 
taken up into the ER by sarcoplasmic and endoplasmic
reticulum Ca"-ATPase (SERCA). With respect to the 
regulation of Ca" level, the involvement of CRT and 
SERCA2b38.39' or the IP3-receptor"' has been reported. 
Johnson et al .31' demonstrated that CRT could bind 
with SERCA2b through the lectin site of CRT, and 
suppressed Ca"-ATPase activity under conditions of a 
full Ca2 store in the ER. On the other hand, IP3-receptor-
dependent Ca 2+ release was suppressed in CRT-deficient 
MEF cells, suggesting that CRT is functionally in-
volved in the IP3-receptor pathway. Furthermore, the 
store-operated Ca" release from the ER was shown to 
be suppressed by overexpression of CRT protein." -131 
These findings indicate that CRT is not only a reser-
voir of Ca 2+ but also a regulator of Ca 21 -homeostasis in 
the ER.
[3] Other miscellaneous functions of CRT in and 
  out of the ER 
 CRT is involved in cell adhesion by affecting 
integrin-related cell signaling."' In CRT-deficient em-
bryonic stem cells, integrin-mediated Ca 21 influx was 
impaired leading to a decrease in cell adhesion to 
fibronectin and laminin. It is still not clear whether 
CRT affects integrin directly or indirectly to regulate 
cell adhesion signaling. Although CRT was reported to 
bind to the cytoplasmic tail of integrin in vitro"', it is 
not known how CRT exits the ER and is transported 
to the cytosol. 
 Cell surface expression of CRT has also been re-
ported in various cell types, and may be related with 
cell adhesion and migration." The removal of the C-
terminal ER-retrieval signal (KDEL) by proteolysis 
may be one mechanism for the extracellular secretion of 
CRT, but the mechanism involved is still unclear. The 
cell surface CRT may modulate cell adhesion by binding 
with extracellular matrix proteins, such as fibrinogen"), 
laminin4", and thrombospondin.48' Furthermore, it was 
reported that CRT or its fragments inhibited 
angiogenesis and suppressed tumor growth."' Although, 
this suggests some potential for use in cancer therapy, 
the molecular mechanism of CRT actions at the cell 
surface is not fully understood. 
 Extracellular CRT is implicated in the pathological 
processes of autoimmune diseases. Autoantibodies 
against CRT were found in approximately 40% of pa-
tients with systemic lupus erythematosus (SLE)50', pa-
tients with secondary Sjogrens syndrome"', rheuma-
toid arthritis"), celiac disease"), complete congenital 
heart block 14) , and halothane hepatitis.") CRT is 
known to bind to complement, C l q, and compete with 
antibodies for binding to C l q and inhibition of C 1 q-
dependent hemolysis.56' In autoimmune diseases,
impairment of the classical pathway of compliment 
causes a failure to clear immune complex, resulting in 
progression of the disease. Therefore, extracellular CRT 
may contribute to the progression of autoimmune dis-
eases by preventing clearance of immune complex. 
Extracellular CRT is not only an autoantigen but also 
an enhancer for various autoimmune diseases, and 
may be involved in each pathological mechanism. 
However, it is still controversial whether CRT is ex-
ported from necrotic cells or apoptotic cells under 
pathologic conditions. 
 Recently, it has been reported that cytosolic CRT 
functions as an export factor for multiple nuclear hor-
mone receptors, such as steroid hormone, non-steroid 
hormone, and orphan receptors.","' This novel func-
tion of CRT is consistent with previous findings that 
CRT suppresses the transactivation of nuclear hor-
mone receptors including androgen receptor"' and vi-
tamin D"', and also supports the molecular mecha-
nism. However, the mechanisms by which CRT 
molecules are transported into, and retained in, the 
cytosol/nucleus are undefined.
Biological significance of CRT in development 
 It was shown that CRT is essential for cardiac and 
neural development in mice.40, 61' CRT gene knockout 
mice showed embryonic lethality at day 14.5-16.5 with 
insufficient development of the heart and neuronal 
tube. CRT is well expressed in embryonic rat heart 
but its expression is significantly suppressed after 
birth."' Cardiac development is believed to be regu-
lated cooperatively by a variety of transcription fac-
tors (e.g. GATA, MEF2, HAND, COUP-TFII, Nkx2.5, 
TBX5, NF-ATc, Smad6, Pax3, RXR/RAR, TEF-1, WT-
1, etc.).63' Interestingly, the gene expression of CRT is 
known to be regulated by a transcription factor, 
Nkx2.5, that is involved in the regulation of the gene 
expression for cardiac development.") CRT-deficient 
embryonic cells showed an impaired nuclear import of 
nuclear factor of activated T cell (NF-AT3), a tran-
scription factor, indicating that CRT functions in cardiac 
development as a component of the Ca" /calcineurin/ 
NF-AT/GATA-4 transcription pathway.40' Actually, car-
diac-specific expression of calcineurin reversed the em-
bryonic lethality of CRT-deficient mouse.") 
 It was also reported that CRT transgenic mice suf-
fer a complete heart block and sudden death."' In that 
study, it was described that CRT-dependent cardiac 
block involves an impairment of both the L-type Ca" 
channel and gap junction connexins (Cx40 and Cx43). 
Also observed was a decrease of phosphorylated Cx43
in CRT transgenic heart, suggesting that the functions 
of protein kinases are altered via the regulation of Ca" 
homeostasis. The study indicates that the overexpression 
of CRT affects not the morphogenesis but the physio-
logical function of cardiomyoblasts. The overall 
mechanism of the dephosphorylation of Cx43 in CRT 
transgenic heart cells is not known but may involve 
the altered regulation of protein kinase pathways. 
These studies suggest that CRT plays a vital role in 
cardiac differentiation and function, though how has 
not been fully clarified.
The regulation of apoptosis by CRT in 
myocardiac H9c2 cells 
 Recently, we investigated the biological role of CRT 
using rat cardiomyoblast H9c2 cells transfected with 
the CRT gene."' In the present study, we examined 
the effect of overexpression of CRT on the cardiac dif-
ferentiation of H9c2 cells. When cultured in a differen-
tiation medium containing 1 % FCS and 10 nM RA, the 
overexpressers showed a decrease in cell number and 
an increase in DNA double strand breaks, indicating 
that they were highly susceptible to apoptosis com-
pared with controls. We found that Akt signaling was 
significantly suppressed in the gene-transfected cells 
compared with the mock-transfected controls during 
the differentiation. In control cells, the phosphorylation 
and activity of Akt showed a gradual decline during 
the culture. In contrast, the decline was significantly 
accelerated in the gene-transfected cells. Furthermore, 
in the transfectants, expression of protein phosphatase 
2A (PP2A), a Ser/Thr protein phosphatase, was signifi-
cantly upregulated in response to the treatment, im-
plying that the suppression of Akt signaling was due 
to dephosphorylation of Akt caused by the 
upregulated PP2A expression. Consequently, we con-
clude that the overexpression of CRT promotes the 
differentiation-dependent apoptosis of H9c2 cells 
through suppression of the Akt signaling pathway via 
upregulation of PP2A expression caused by altered C 
a2+ homeostasis. This is the first report of the Akt-
mediated cell survival signaling pathway being modu-
lated by the introduction of the CRT gene. 
 Apoptosis is regulated by several signaling path-
ways including stress-activated protein kinases (SAPKs), 
mitogen-activated protein kinases (MAPKs), and Akt/ 
protein kinase B.6S' The Akt signaling pathway is a 
well characterized signal for cell survival which leads 
to the phosphorylation of BAD to dissociate Bcl-2 
from its complex, to the expression of Bcl-2 through 
transactivation of E2F, and to the inhibition of GSK-3
Apoptosis stimuli
Figure 3. Regulation of cell survival signaling by Akt/pro-
tein kinase B. 
Alit is a Ser/Thr kinase, the enzyme activity of which is 
regulated by its own phosphorylated state. Akt signaling 
leads to the phosphorylation of BAD to dissociate Bcl-2 from 
its complex, resulting in anti-apoptosis. Akt also phosphorylates 
caspases 9, resulting in its inactivation. Furthermore, Akt sig-
naling leads to the phosphorylation of IKK a to activate the 
NFkB pathway, and also of cAMP-responsive element bind-
ing protein (CREB). In both cases, the specific genes for cell 
survival were upregulated to function as anti-apoptosis.
as well as caspases (Fig. 3).69, 70' Akt is an important 
cell survival and anti-apoptotic signal in differentiat-
ing H9c2 cells. Although Akt is regulated by up-
stream t such 1 7 L' 7 7' 'L 1 stream signals such as phospnat~dyiinositol 3-MI
(P13K) and PDK 1 /PDK2, the upstream signals are not 
influenced by overexpression of CRT during differen-
tiation in H9c2 cells. To identify other regulators of 
Akt activity and signaling, we focused on protein 
phosphatases that could regulate the activity by 
dephosphorylating phosphoseryl or phosphothreonyl 
residues of Akt. We found that the expression and ac-
tivity of PP2A were significantly increased in the 
gene-transfectants compared with the controls 
throughout the differentiation. Ser/Thr-specific PP2A 
is present in most eukaryotic cells and functions in a 
variety of processes including cell cycle regulation, 
cell differentiation, and signal transduction.71' 72' PP2A 
is known to modulate the activities of several kinases 
in vitro and in vivo, such as phosphorylase kinase, the 
MAPKs, the calmodulin-dependent kinase, PKA, Akt/ 
PKB, PKC, p70S6 kinase, the IkB kinase and the Cdks 
.73' Akt is inactivated in vitro by PP2A and is acti-
vated in cells upon treatment with okadaic acid and 
calyculin A73', suggesting that Akt is a putative sub-
strate for PP2A. We also observed that calyculin A in-
hibited PP2A activity to prevent the differentiation-
induced dephosphorylation and inactivation of Akt in
cells transfected with the CRT gene. Collectively, 
these results strongly suggest that PP2A acted as a 
regulator for dephosphorylation and inactivation of 
Akt in the transfected H9c2 cells during their differ-
entiation. 
 In a report by Nakamura et al."), overexpression of 
CRT resulted in increased sensitivity of HeLa cells to 
both thapsigargin- and staurosporine-induced apoptosis. 
The authors suggested that overexpression of CRT af-
fects the communication between the ER and mito-
chondria to increase the sensitivity to apoptosis via 
the altered Ca 2+ homeostasis, and this has recently 
been supported by the study of Arnaudeau et al."' 
Pinton et al."' reported that the releasable Ca 21 con-
centration in the ER is important for ceramide-induced 
apoptosis, and . also showed that overexpression of 
CRT enhanced the ceramide-induced apoptosis in 
HeLa cells. Furthermore, a necrosis-promoting effect of 
CRT is also reported in C. elegance."' These results 
seem to support our findings that CRT expression 
positively regulates the apoptotic process under spe-
cific cellular conditions such as during cell differentia-
tion. Oyadomari et al."', however, reported that the 
overexpression of CRT actually protects pancreatic ~ 
cells from nitric oxide-induced apoptosis, whereas Zhu 
and Wang"' found that CRT antisense oligonucleotide 
down-regulated CRT protein production and signifi-
cantly increased the sensitivity to calcium ionophore-
induced apoptosis. This discrepancy may be due to 
'the different i ii types , • i. a 'the different c ll types, stress timuli, and experimen-
tal models used, but further investigation is needed 
into the molecular mechanism of the apoptotic process 
in each of these experimental models. 
 Previous study indicates that an enhanced expres-
sion of CRT increases the Ca21- storage capacity of the 
ER." CRT also appears to control store operated Ca 21 
influx",42.80,81) and to alter Ca" transport by SERCA2b.39' 
Very recently, Scorrano et al." has reported that Ca 21 
reserved in the ER acts as an important gateway for 
apoptosis via its influence on mitochondrial Ca 2'- ho-
meostasis. Overexpression of CRT also influences the 
mitochondrial Ca 2+ homeostasis.") Together, the en-
hanced susceptibility to apoptosis in CRT-overexpressing 
H9c2 cells may also be due to the modulation of 
mitochondrial Ca" homeostasis by the altered Ca" re-
sponses in the ER overexpressing CRT. 
 In our study, the intracellular concentration of free 
Ca" was higher in the CRT gene-transfectants than in 
the controls throughout the differentiation. To eluci-
date whether altered Ca" homeostasis could affect 
PP2Aca expression and Akt signaling, the effect of Ca" 
modulators on the expression and signaling was 
tested. The results showed that the PP2Ac a expression
increased to suppress the Akt signaling on treatment 
with thapsigargin and ionomycin, which increased the 
level of intracellular Ca". Furthermore, upon treat-
ment with BAPTA-AM, which decreases intracellular 
Ca" levels, PP2Ac a expression decreased to enhance 
the Akt signaling. These results strongly suggest that 
PP2Ac a gene expression is controlled by intracellular 
Ca" levels and homeostasis. The gene structure and 
regulation of PP2A has been elucidated in humans 
and rats. In both PP2Ac a genes, the promoter region 
is rich in GC and lacks TATA and CCAAT sequences, 
consistent with a housekeeping gene .12, 83' The PP2Ac a 
gene contains several Sp 1 binding sites and a poten-
tial cAMP-responsive element (CRE). CRE is regulated 
by a Ca2+-regulated transcription factor, CRE binding 
protein (CREB), through Ca2+ /calmodulin dependent 
kinases (CaMKs)84', but no Ca2+-dependent regulation 
of Spl function is known. In H9c2 cells, expression of 
the PP2Ac a gene is upregulated by an increase in 
cytoplasmic free Ca 21 induced by thapsigargin 
through the activation of CRE (Yasuoka and Ihara, 
unpublished data). Although elevations in Ca 2' act as 
a signal, a prolonged increase in the concentration of 
Ca" can be lethal.") Moreover, transcription factors are 
activated differently by the amplitude and duration of 
the response to Ca".") Therefore, overexpression of 
CRT may affect the transcriptional regulation of 
PP2Ac a mainly via the regulation of Ca 2' homeosta-
sis in H9c2 cells. 
 CRT functions as a molecular chaperone in the ER. 
This chaperone function may also contribute to the 
differentiation-induced apoptosis of H9c2 cells 
overexpressing CRT by affecting the ER stress signal-
ing pathway. When the ER is under stress, resident 
kinases such as IRE I and PERK are activated to pro-
duce stress signals through a change in the luminal 
environment, for example, an accumulation of un-
folded proteins in the ER." Urano et al."' demon-
strated that IRE I activates c-Jun amino terminal 
kinase (JNK) in response to ER stress. This strongly 
suggests that endogenous signals initiated in the ER 
modulate cytoplasmic signal transduction cascades. 
Nakagawa et al.") reported that caspase-12 is acti-
vated in the ER specifically in response to ER stress. 
Therefore, it is also possible that a pathway contain-
ing caspase-12 is involved in the differentiation-
induced apoptosis of H9c2 cells overexpressing CRT. 
Recently, we have found that overexpression of CRT 
promotes apoptosis in H9c2 cells under oxidative 
stress due to H2O2, and that the apoptosis is triggered 
by an increase of cytoplasmic free Ca" through en-
hancement of the inactivation and degradation of 
SERCA2a via increased interaction with CRT under
Figure 4. Working hypothesis for the apoptosis in CRT-
overexpressing H9c2 cells. 
In CRT-overexpressing cells, Ca" homeostasis in the ER is 
changed to increase cytosolic free Ca 2+ and load Ca 21 into mi-
tochondria under stress conditions such as oxidative stress. 
This causes the activation of Ca"-dependent transcription of 
specific genes such as the PP2Ac a gene. Upregulation of 
PP2A expression leads to the suppression of Akt signaling, 
resulting in an increase in susceptibility to apoptosis. 
Alternatively, Ca 21 overload in the mitochondria also triggers 
apoptosis.
the stress (Ihara et al., unpublished results). The en-
hanced chaperone-like interaction between CRT and 
SERCA2a under stress may be part of the cause of al-
tered Ca 2+ homeostasis and subsequent activation of 
signaling cascade of apoptosis. Finally, a working hy-
pothesis for the mechanism of apoptosis regulated by 
CRT is indicated in Fig. 4.
Conclusion 
 When overexpressed, CRT modulates Akt signaling 
to promote differentiation-induced apoptosis in H9c2 
cells. CRT is essential for cardiac development, and its 
expression is strictly downregulated in mature 
cardiomyocytes. As CRT functions to promote apoptosis, 
it may have some important physiological function in 
the process of cardiogenesis. Although further investi-
gation of the correlation between CRT expression and 
apoptotic signals is required, our recent study has re-
vealed a novel pathway of cellular signaling for 
apoptosis and its regulation via a change in the ER 
luminal environment and Ca" homeostasis.
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